Načítá se...
Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children
BACKGROUND: There continues to be uncertainty about whether piperacillin/tazobactam (TZP) increases the risk of AKI in critically ill pediatric patients. We sought to compare rates of AKI among critically ill children treated with TZP or cefepime, an alternative frequently used in intensive care uni...
Uloženo v:
| Vydáno v: | J Am Soc Nephrol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6830781/ https://ncbi.nlm.nih.gov/pubmed/31501354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018121223 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|